PacBio Revio (or equal) Sequencing supplies

The Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services is seeking PacBio Revio (or equal) sequencing supplies for the National Center for Toxicological Research. The procurement involves acquiring 10 Revio SMRT Cell Trays, 10 Revio SPRQ sequencing plates, and 1 Revio SPRQ polymerase kit to support research aimed at identifying mutations induced by nitrosamines in mammalian cell line DNA. The solicitation (RFQ 75F40125Q129497) requires sequencing kits compatible with the FDA's existing PacBio Revio instrument (serial #84183), with a specific focus on research-grade laboratory equipment. Quotes must be submitted by May 30, 2025, at 10:00 AM Central Time, with evaluation likely centered on technical compatibility, pricing, and ability to meet the specific scientific research requirements. The procurement will follow a firm fixed-price commercial product arrangement, emphasizing precise technical specifications and performance capabilities.

The contract is designated as a total small business set-aside under NAICS category 334516 (Analytical Laboratory Instrument Manufacturing), with a small business size standard of 1,000 employees. Potential vendors must be prepared to deliver the sequencing supplies within one month of contract award to the National Center for Toxicological Research located in Jefferson, Arkansas. While no specific incumbent contractor is mentioned, the solicitation indicates a need for precise scientific equipment that meets exact specifications for mutation research. Pricing must be inclusive of shipping, and vendors should demonstrate their ability to provide high-quality sequencing supplies that are fully compatible with the existing PacBio Revio instrument. The procurement represents a targeted acquisition of specialized laboratory equipment designed to support advanced toxicological research methodologies.